Recent News

• 11.13.2025 - Q3 2025 Earnings
• 11.12.2025 - Publishing of Q3 results, after the close of the US market.
• 09.10.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference New York
• 09.04.2025 - Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
• 08.22.2025 - Analyst_Arvid_Necander_DNBCarnegie
• 08.21.2025 - Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
• 08.20.2025 - Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia
• 08.14.2025 - Q2 2025 Earnings Call
• 08.14.2025 - Q2 2025 Earnings
• 08.13.2025 - Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Recent Filings

• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.13.2025 - EX-99.1 EX-99.1
• 07.28.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 07.28.2025 - EX-99.1 EX-99.1
• 07.28.2025 - F-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 07.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]